# Therapeutic Hypotheses: Neuron-Specific Autophagy Defects in ALS
---
## Hypothesis 1: Axonal Transport Defect in Autophagosome Maturation
**Title:** C9orf72 hexanucleotide expansion impairs retrograde autophagosome transport in motor neuron axons
**Mechanism:** C9orf72 forms a complex with RAB7 and the dynein-dynactin motor complex to regulate autophagosome retrograde transport. GGGGCC repeat expansions cause C9orf72 haploinsufficiency, disrupting this complex and trapping immature autophagosomes in the distal axon. This creates a "traffic jam" preventing delivery of autophagic cargo to the soma for lysosomal degradation.
**Target gene/protein/pathway:** C9orf72 → RAB7A → dynein-dynactin complex → microtubule network
**Supporting evidence:**
- C9orf72 regulates Rab-mediated membrane trafficking (PMID: 25403846)
- C9orf72 interacts with RAB7L1 and autophagy regulators (PMID: 25920554)
- iPSC-derived motor neurons from C9orf72 patients show axonal autophagosome accumulation (PMID: 29530934)
**Predicted experiment:** Live-cell imaging of mCherry-eGFP-LC3B autophagosomes in iPSC-derived motor neurons from C9orf72 expansion carriers vs. isogenic controls, measuring axonal transport velocity, flux, and fusion events at distal vs. proximal compartments using microfluidic chambers.
**Confidence:** 0.78
---
## Hypothesis 2: Motor Neuron-Specific Mitophagy Failure via OPTN-TBK1 Axis
**Title:** OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-independent mitophagy in lower motor neurons
**Mechanism:** OPTN serves as the primary autophagy receptor for damaged mitochondria in neurons via its LC3-interacting region (LIR) and ubiquitin-binding domain. TBK1 phosphorylates OPTN at S177, enhancing its affinity for ubiquitinated mitochondrial proteins. ALS-causing mutations in either gene impair this phospho-regulation, causing accumulation of dysfunctional mitochondria specifically in motor neurons—which have exceptionally high energy demands and limited mitophagy redundancy compared to other cell types.
**Target gene/protein/pathway:** PINK1/PARKIN-independent pathway: TBK1 → OPTN (S177) → LC3G → isolation membrane recruitment
**Supporting evidence:**
- OPTN mutations cause ALS (PMID: 21109225, 21784250)
- TBK1 mutations identified in ALS cohorts (PMID: 25241285)
- OPTN deficiency leads to mitochondrial fragmentation and ROS accumulation (PMID: 29748552)
- Neurons uniquely depend on OPTN-mediated mitophagy (PMID: 31359046)
**Predicted experiment:** Mito-Keima sensor quantification in spinal motor neurons vs. cortical neurons from OPTN knockout or ALS-mutant knock-in mice following FCCP treatment, with comparative measurement of mitochondrial membrane potential recovery, ROS levels, and ATP production.
**Confidence:** 0.72
---
## Hypothesis 3: TDP-43 Pathology Disrupts SNARE-Mediated Autophagosome-Lysosome Fusion
**Title:** Cytosolic TDP-43 aggregation sequesters SNAP29 and syntaxin-17, blocking autophagosome-lysosome fusion
**Mechanism:** Under pathological conditions, mislocalized TDP-43 aggregates in the cytoplasm sequester the Q-soluble SNARE protein SNAP29 and the R-soluble SNARE syntaxin-17 (STX17), preventing formation of the trans-SNARE complex required for autophagosome-lysosome fusion. This creates a secondary autophagy block independent of initiation, explaining why early-stage ALS shows increased autophagosomes while late-stage shows aggregate accumulation.
**Target gene/protein/pathway:** TDP-43 (TARDBP) → SNAP29 → STX17/VAMP8 SNARE complex → autophagosome-lysosome fusion
**Supporting evidence:**
- TDP-43 pathology is present in >95% of ALS cases (PMID: 18697238)
- SNAP29 dysfunction causes neurodevelopmental defects mimicking TDP-43 loss (PMID: 26945057)
- STX17 localizes to completed autophagosomes; its knockdown mimics ALS autophagy phenotypes (PMID: 26577887)
- TDP-43 regulates SNAP29 mRNA splicing (PMID: 31138729)
**Predicted experiment:** Co-immunoprecipitation of SNAP29 and STX17 from laser-captured spinal cord motor neurons of ALS patients vs. controls, with validation using in vitro reconstitution assays measuring SNARE complex formation and liposome fusion rates.
**Confidence:** 0.69
---
## Hypothesis 4: VCP Mutations Decouple Autophagy from Ubiquitin-Proteasome Crosstalk
**Title:** VCP/p97 ATPase mutations impair extraction of ubiquitinated autophagy substrates, causing proteasome-autophagy flux obstruction
**Mechanism:** VCP extracts ubiquitinated proteins from ER membranes and protein aggregates for proteasomal degradation. ALS-causing VCP mutations (e.g., R155H) reduce ATPase activity and alter substrate recognition. This disrupts the coordination between proteasomal and autophagic clearance pathways, causing ubiquitinated proteins to accumulate in aggresome-like structures that overwhelm remaining autophagy capacity—particularly damaging in neurons where protein turnover is already stressed.
**Target gene/protein/pathway:** VCP (hexamer) → p62/SQSTM1 → ubiquitinated protein aggregates → proteasome/autophagy
**Supporting evidence:**
- VCP mutations cause familial ALS (PMID: 20562850, 20180545)
- VCP regulates autophagosome maturation (PMID: 20818175)
- VCP mutations cause ubiquitin-positive nuclear and cytoplasmic inclusions (PMID: 21305278)
- p62 body formation is enhanced but clearance impaired (PMID: 27466187)
**Predicted experiment:** Proteomic analysis of VCP-associated complexes in motor neurons from VCP R155H knock-in mice using TurboID labeling, with quantitative assessment of ubiquitinated substrate flux through proteasome vs. autophagy pathways over time.
**Confidence:** 0.